Back to Trades
GUGGENHIME ANDREW
PRESIDENT AND CFOCIK 0001230724
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 2
- Active
- 2025–2026
Across 8 filings between 2025–2026, GUGGENHIME ANDREW, PRESIDENT AND CFO, has disclosed $6.9M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.6M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Aug 5 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | $538.9K |
| Jul 6 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | $572.8K |
| Jun 18 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Sell | $530.0K |
| Mar 2 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Grant | $4.6M |
| Feb 20 | CRBU Caribou Biosciences, Inc. | GUGGENHIME ANDREW | Director | Award | $81.0K |
| Jan 16 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Gift | $0 |
| Sep 10 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Tax withheld | $93.7K |
| Sep 4 | PCVX Vaxcyte, Inc. | GUGGENHIME ANDREW | PRESIDENT AND CFO | Tax withheld | $160.3K |
8 filings